Picchiarelli G, Dupuis L
Cell Stress. 2020; 4(4):76-91.
PMID: 32292882
PMC: 7146060.
DOI: 10.15698/cst2020.04.217.
Yuan R, Liu N, Yang J, Peng J, Liu L, Guo X
Medicine (Baltimore). 2018; 97(35):e12081.
PMID: 30170425
PMC: 6392918.
DOI: 10.1097/MD.0000000000012081.
Lee S, Won J, Park S, Lee S, Chang K, Kim J
J Phys Ther Sci. 2017; 29(4):760-762.
PMID: 28533625
PMC: 5430288.
DOI: 10.1589/jpts.29.760.
Oaks A, Zamarbide M, Tambunan D, Santini E, Di Costanzo S, Pond H
Cereb Cortex. 2016; 27(2):1670-1685.
PMID: 26826102
PMC: 6250986.
DOI: 10.1093/cercor/bhw009.
Lee M, Won J, Lee S, Hong Y, Kim J, Hong Y
J Lifestyle Med. 2016; 5(2):35-8.
PMID: 26770889
PMC: 4711957.
DOI: 10.15280/jlm.2015.5.2.35.
Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications.
Yoo H
Exp Neurobiol. 2015; 24(4):257-72.
PMID: 26713075
PMC: 4688327.
DOI: 10.5607/en.2015.24.4.257.
Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures.
Prilutsky D, Kho A, Palmer N, Bhakar A, Smedemark-Margulies N, Kong S
Mol Autism. 2015; 6:66.
PMID: 26697163
PMC: 4687343.
DOI: 10.1186/s13229-015-0061-9.
Minocycline: far beyond an antibiotic.
Garrido-Mesa N, Zarzuelo A, Galvez J
Br J Pharmacol. 2013; 169(2):337-52.
PMID: 23441623
PMC: 3651660.
DOI: 10.1111/bph.12139.
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.
Portis S, Giunta B, Obregon D, Tan J
Int J Physiol Pathophysiol Pharmacol. 2012; 4(3):140-8.
PMID: 23071871
PMC: 3466494.
Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.
Siller S, Broadie K
Neural Plast. 2012; 2012:124548.
PMID: 22685676
PMC: 3364018.
DOI: 10.1155/2012/124548.
In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.
Coffee Jr R, Williamson A, Adkins C, Gray M, Page T, Broadie K
Hum Mol Genet. 2011; 21(4):900-15.
PMID: 22080836
PMC: 3263990.
DOI: 10.1093/hmg/ddr527.
The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.
Fitzpatrick C, Lombroso P
Front Neuroanat. 2011; 5:47.
PMID: 21863137
PMC: 3149150.
DOI: 10.3389/fnana.2011.00047.
Fragile X-associated disorders: a clinical overview.
Gallagher A, Hallahan B
J Neurol. 2011; 259(3):401-13.
PMID: 21748281
DOI: 10.1007/s00415-011-6161-3.
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.
Siller S, Broadie K
Dis Model Mech. 2011; 4(5):673-85.
PMID: 21669931
PMC: 3180232.
DOI: 10.1242/dmm.008045.
Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype.
Klemmer P, Meredith R, Holmgren C, Klychnikov O, Stahl-Zeng J, Loos M
J Biol Chem. 2011; 286(29):25495-504.
PMID: 21596744
PMC: 3138307.
DOI: 10.1074/jbc.M110.210260.
Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
Yuskaitis C, Beurel E, Jope R
Biochim Biophys Acta. 2010; 1802(11):1006-12.
PMID: 20600866
PMC: 2942952.
DOI: 10.1016/j.bbadis.2010.06.015.
GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
Mines M, Yuskaitis C, King M, Beurel E, Jope R
PLoS One. 2010; 5(3):e9706.
PMID: 20300527
PMC: 2838793.
DOI: 10.1371/journal.pone.0009706.
Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.
Gladding C, Fitzjohn S, Molnar E
Pharmacol Rev. 2009; 61(4):395-412.
PMID: 19926678
PMC: 2802426.
DOI: 10.1124/pr.109.001735.
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses.
Verhoeven W, Tuinier S, van der Burgt I
Biologics. 2009; 2(3):409-17.
PMID: 19707372
PMC: 2721407.
DOI: 10.2147/btt.s3053.
Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.
Walter E, Mazaika P, Reiss A
Neuroscience. 2009; 164(1):257-71.
PMID: 19376197
PMC: 2795482.
DOI: 10.1016/j.neuroscience.2009.04.033.